title: Interstate dermatopathology interpretations--50 separate licenses?
abstract: The increasing bureaucracy of health care has had a serious negative impact on physicians and patients for the last fifteen years. We report an example of this trend involving the interstate interpretation of dermatopathology specimens, which resulted in a significant interruption of diagnostic services to a large number of dermatologists. Temporary and long term solutions are discussed with the hope that dialogue and political consensus-building can bring resolution to the problem.
authors.affiliation: Division of Dermatology, Wright State University School of Medicine, USA. tolsenderm@aol.com
authors.forename: Thomas George
authors.initials: TG
authors.lastname: Olsen
authors.forename: Theresa Ann
authors.initials: TA
authors.lastname: Feeser
authors.forename: Peter Leon
authors.initials: PL
authors.lastname: Jenkins
mesh_terms: D000068:Accreditation; D001706:Biopsy; D003880:Dermatology / Q000331:legislation & jurisprudence*; D003954:Diagnostic Services / Q000331:legislation & jurisprudence*; D006801:Humans; D007753:Laboratories / Q000331:legislation & jurisprudence*; D008007:Licensure, Medical / Q000331:legislation & jurisprudence*; D009657:North Carolina; D009820:Ohio; D010338:Pathology, Clinical / Q000331:legislation & jurisprudence*; D012867:Skin / Q000473:pathology; D017216:Telemedicine / Q000331:legislation & jurisprudence*; D014481:United States